|
|
Volumn 16, Issue 4, 2002, Pages 241-246
|
|
Validation of a high-performance liquid chromatographic method for the enantiospecific quantitation of zopiclone in plasma
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOMOLECULES;
CHROMATOGRAPHIC ANALYSIS;
DRUG INTERACTIONS;
ENANTIOMERS;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
QUALITY CONTROL;
BENZODIAZEPINES;
CLINICAL EFFECTS;
ENANTIOSPECIFIC;
HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC METHODS;
HPLC METHOD;
INTERNAL STANDARDS;
METHODS OF ANALYSIS;
RACEMIC MIXTURES;
STRUCTURAL ANALOGUE;
ZOPICLONE;
METABOLITES;
6 (3' CHLOROPYRID 6' YL) 7 [(4″ METHYLPIPERAZINYL)CARBONYLOXY] 5,7 DIHYDROPYRROLO(3,4 BETA)PYRAZIN 5 ONE;
6 (3' CHLOROPYRID 6' YL) 7 [(PIPERAZINYL)CARBONYLOXY] 5,7 DIHYDROPYRROLO(3,4 BETA)PYRAZIN 5 ONE;
6 (3' CHLOROQUINOL 2' YL) 7 [(4″ METHYLPIPERAZINYL)CARBONYLOXY] 5,7 DIHYDROPYRROLO(3,4 BETA)PYRAZIN 5 ONE;
DRUG ANALOG;
DRUG METABOLITE;
UNCLASSIFIED DRUG;
ZOPICLONE;
ACCURACY;
ARTICLE;
BLOOD ANALYSIS;
BLOOD SAMPLING;
CALIBRATION;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG DETERMINATION;
DRUG METABOLISM;
DRUG OVERDOSE;
DRUG STRUCTURE;
DRUG URINE LEVEL;
ELUTION;
ENANTIOMER;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
LINEAR SYSTEM;
MENTAL PATIENT;
PREDICTION;
QUALITY CONTROL;
QUANTITATIVE ANALYSIS;
STANDARD;
VALIDATION PROCESS;
|
|
EID: 0036100025
PISSN: 02693879
EISSN: None
Source Type: Journal
DOI: 10.1002/bmc.135 Document Type: Article |
|
Times cited : (20)
|
|
References (9)
|
